The effect of sudden clozapine discontinuation on management of schizophrenic patients: A retrospective controlled study

Journal of Clinical Psychiatry

Volumn 67, Issue 8, 2006, Pages 1204-1208

  Miodownik, Chanoch ^a   Lerner, Vladimir ^a   Kibari, Adi ^b   Toder, Doron ^b   Cohen, Hagit ^a  

^a MENTAL HEALTH CENTER   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG WITHDRAWAL; FEMALE; HOSPITAL DISCHARGE; HUMAN; MALE; MEDICAL RECORD; PRIORITY JOURNAL; REMISSION; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA;

EID: 33748968821     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v67n0805     Document Type: Article

References (28)

1. Buchanan RW, Breier A, Kirkpatrick B, et al. Positive and negative symptom response to clozapine in schizophrenic patients with and without the deficit syndrome. Am J Psychiatry 1998;155:751-760
2. Lindstrom LH. The effect of long-term treatment with clozapine in schizophrenia: a retrospective study in 96 patients treated with clozapine for up to 13 years. Acta Psychiatr Scand 1988;77:524-529
3. Umbricht DSG, Lieberman JA, Kane JM. The clinical efficacy of clozapine in the treatment of schizophrenia. Rev Contemp Pharmacother 1995;6:165-186
4. McElroy SL, Dessain EC, Pope HG Jr, et al. Clozapine in the treatment of psychotic mood disorders, schizoaffective disorder, and schizophrenia. J Clin Psychiatry 1991;52:411-414
5. Wagstaff A, Perry C. Clozapine: in prevention of suicide in patients with schizophrenia or schizoaffective disorder. CNS Drugs 2003;17:273-280; discussion 281-283
6. Javitt DC. Management of negative symptoms of schizophrenia. Curr Psychiatry Rep 2001;3:413-417
7. Potkin SG, Fleming K, Jin Y, et al. Clozapine enhances neurocognition and clinical symptomatology more than standard neuroleptics. J Clin Psychopharmacol 2001;21:479-483
8. Galletly CA, Clark CR, McFarlane AC, et al. The effect of clozapine on the speed and accuracy of information processing in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2000;24:1329-1338
9. Lacro JP, Dunn LB, Dolder CR, et al. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry 2002;63:892-909
10. Ayuso-Gutierrez JL, del Rio Vega JM. Factors influencing relapse in the long-term course of schizophrenia. Schizophr Res 1997;28:199-206
11. Kinon BJ, Lieberman JA. Mechanisms of action of atypical antipsychotic drugs: a critical analysis. Psychopharmacology (Berl) 1996;124:2-34
12. Ekblom B, Eriksson K, Lindstrom LH. Supersensitivity psychosis in schizophrenic patients after sudden clozapine withdrawal. Psychopharmacology (Berl) 1984;83:293-294
13. Perenyi A, Kuncz E, Bagdy G. Early relapse after sudden withdrawal or dose reduction of clozapine [letter]. Psychopharmacology (Berl) 1985;86:244
14. Alphs LD, Lee HS. Comparison of withdrawal of typical and atypical antipsychotic drugs: a case study. J Clin Psychiatry 1991;52:346-348
15. Parsa MA, al-Lahham YH, Ramirez LF, et al. Prolonged psychotic relapse after abrupt clozapine withdrawal [letter]. J Clin Psychopharmacol 1993;13:154-155
16. Meltzer HY, Lee MA, Ranjan R, et al. Relapse following clozapine withdrawal: effect of neuroleptic drugs and cyproheptadine. Psychopharmacology (Berl) 1996;124:176-187
17. Shiovitz TM, Welke TL, Tigel PD, et al. Cholinergic rebound and rapid onset psychosis following abrupt clozapine withdrawal. Schizophr Bull 1996;22:591-595
18. Stanilla JK, de Leon J, Simpson GM. Clozapine withdrawal resulting in delirium with psychosis: a report of three cases. J Clin Psychiatry 1997;58:252-255
19. Goudie AJ, Smith JA, Robertson A, et al. Clozapine as a drug of dependence. Psychopharmacology (Berl) 1999;142:369-374
20. Szafranski T, Gmurkowski K. Clozapine withdrawal: a review [in Polish]. Psychiatr Pol 1999;33:51-67
21. Llorca PM, Vaiva G, Lancon C. Supersensitivity psychosis in patients with schizophrenia after sudden olanzapine withdrawal [letter]. Can J Psychiatry 2001;46:87-88
22. Margolese HC, Chouinard G, Beauclair L, et al. Therapeutic tolerance and rebound psychosis during quetiapine maintenance monotherapy in patients with schizophrenia and schizoaffective disorder. J Clin Psychopharmacol 2002;22:347-352
23. Berkow R, Beers MH, Burs M, eds. The Merck Manual of Diagnosis and Therapy. 17th ed. Rahway, NJ: Merck Research Laboratories; 1999
24. Ellenbroek BA. Treatment of schizophrenia: a clinical and preclinical evaluation of neuroleptic drugs. Pharmacol Ther 1993;57:1-78
25. Kane J, Honigfeld G, Singer J, et al. Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988;45:789-796
26. Kemp R, Kirov G, Everitt B, et al. Randomised controlled trial of compliance therapy: 18-month follow-up. Br J Psychiatry 1998;172:413-419
27. Csernansky JG, Schuchart EK. Relapse and rehospitalisation rates in patients with schizophrenia: effects of second generation antipsychotics. CNS Drugs 2002;16:473-484
28. Zita DF, Goethe J. Helping clozapine help: a role for support groups. Schizophr Bull 2002;28:123-126